Page last updated: 2024-08-17

cysteamine and gemfibrozil

cysteamine has been researched along with gemfibrozil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bodas, M; Gulbins, E; Pehote, G; Silverberg, D; Vij, N1

Reviews

1 review(s) available for cysteamine and gemfibrozil

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

2 other study(ies) available for cysteamine and gemfibrozil

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Autophagy augmentation alleviates cigarette smoke-induced CFTR-dysfunction, ceramide-accumulation and COPD-emphysema pathogenesis.
    Free radical biology & medicine, 2019, 02-01, Volume: 131

    Topics: Acid Ceramidase; Animals; Antioxidants; Autophagy; Bronchi; Case-Control Studies; Cell Line; Ceramides; Complex Mixtures; Cysteamine; Cystic Fibrosis Transmembrane Conductance Regulator; Emphysema; Epithelial Cells; Gemfibrozil; Gene Expression; Humans; Hypolipidemic Agents; Male; Mice; Mice, Inbred C57BL; Nicotiana; Pulmonary Disease, Chronic Obstructive; Smoking

2019